7
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Identification and Characterization of Two Functional Domains within the Murine Heavy-Chain Enhancer

, &
Pages 145-152 | Received 30 Jul 1987, Accepted 19 Oct 1987, Published online: 31 Mar 2023

Literature Cited

  • Augereau, P., and P. Chambon. 1986. The mouse immunoglobulin heavy-chain enhancer: effect on transcription in vitro and binding of proteins present in HeLa and lymphoid B cell extracts. EMBO J. 5:1791-1797.
  • Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocytespecific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33:729-740.
  • Borelli, E., R. Hen, C. Wasylyk, B. Wasylyk, and P. Chambon. 1986. The immunoglobulin heavy chain enhancer is stimulated by the adenovirus type 2 E1a products in mouse fibroblasts. Proc. Natl. Acad. Sci. USA 83:2846-2849.
  • Church, G. M., A. Ephrussi, W. Gilbert, and S. Tonegawa. 1985. Cell type specific contacts to immunoglobulin enhancers in nuclei. Nature (London) 313:608-612.
  • Davidson, L., C. Fromental, P. Augereau, A. Wildeman, M. Zenke, and P. Chambon. 1986. Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts. Nature (London) 323:544-548.
  • Dignam, J. D., R. M. Lebowitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
  • Ephrussi, A., G. M. Church, S. Tonegawa, and W. Gilbert. 1985. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134-140.
  • Falkner, F. G., R. Mocikat, and H. G. Zachau. 1986. Sequences closely related to an immunoglobulin gene promoter/enhancer element occur also upstream of other eukaryotic and of prokaryotic genes. Nucleic Acids Res. 14:8819-8827.
  • Fried, M., and D. M. Crothers. 1981. Equilibria and kinetics of Lac repressor operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:6505-6525.
  • Garner, M. M., and A. Revzin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the E. coli lactose operon regulatory system. Nucleic Acids Res. 9:3047-3060.
  • Gerster, T., P. Matthias, M. Thali, J. Jiricny, and W. Schaffner. 1987. Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer. EMBO J. 6:1323-1330.
  • Gillies, S. D., S. L. Morrison, V. T. Oi, and S. Tonagawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of immunoglobulin heavy chain gene. Cell 33:717-728.
  • Goodbourne, S., H. Burstein, and T. Maniatis. 1986. The human β-interferon gene enhancer is under negative control. Cell 45:601-610.
  • Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
  • Gorman, C. M., P. W. J. Rigby, and D. P. Lane. 1985. Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell 42:519-527.
  • Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
  • Herbomel, P., B. Bourachot, and M. Yaniv. 1984. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653-662.
  • Herr, W., and J. Clarke. 1986. The SV40 enhancer is composed of multiple functional elements that can compensate for one another. Cell 45:461-470.
  • Imler, J.-L., C. Lemaire, C. Wasylyk, and B. Wasylyk. 1987. Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer. Mol. Cell. Biol. 7:2558-2567.
  • Kadesch, T., P. Zervos, and D. Ruezinsky. 1986. Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res. 14:8209-8221.
  • Karin, M., A. Haslinger, H. Holtgreve, R. I. Richards, P. Krauter, H. M. Westphal, and M. Beato. 1984. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (London) 308:513-519.
  • Kholer, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256:495-497.
  • Khoury, G., and P. Gruss. 1983. Enhancer elements. Cell 33:313-314.
  • Klein, G., B. Giovanella, A. Westman, J. S. Stehlin, and D. Mumford. 1975. An EBV-genome negative cell line established from an American Burkitt lymphoma; receptor characteristics, EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319-334.
  • Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
  • Lenardo, M., J. W. Pierce, and D. Baltimore. 1987. Proteinbinding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236:1573-1577.
  • Lennon, G. G., and R. P. Perry. 1985. Cµ-containing transcripts initiate heterogeneously within the IgH enhancer region and contain a novel 5′-nontranslatable exon. Nature (London) 318:475-478.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Moreau, P., R. Hen, B. Wasylyk, R. Everett, M. P. Gaub, and P. Chambon. 1981. The SV40 72 base pair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucleic Acids Res. 9:6047-6068.
  • Nir, U., M. D. Walker, and W. J. Rutter. 1986. Regulation of rat insulin 1 gene expression: evidence for negative regulation in nonpancreatic cells. Proc. Natl. Acad. Sci. USA 83:3180-3184.
  • Ondek, B., A. Shepard, and W. Herr. 1987. Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities. EMBO J. 6:1017-1025.
  • Peterson, C. L., K. Orth, and K. L. Calame. 1986. Binding in vitro of multiple cellular proteins to immunoglobulin heavychain enhancer DNA. Mol. Cell. Biol. 6:4168-4178.
  • Rosenfeld, P. J., and T. J. Kelley. 1986. Purification of nuclear factor I by DNA recognition site affinity chromatography. J. Biol. Chem. 261:1398-1408.
  • Schirm, S., J. Jiricny, and W. Schaffner. 1987. The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. Genes Dev. 1:65-74.
  • Seldon, R. F., K. B. Howie, M. E. Rowe, H. M. Goodman, and D. D. Moore. 1986. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:3173-3179.
  • Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
  • Serfling, E., M. Jasin, and W. Schaffner. 1985. Enhancers and eukaryotic gene expression. Trends Genet. 1:224-230.
  • Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (London) 319:154-158.
  • Staudt, L. M., H. Singh, R. Sen, T. Wirth, P. A. Sharp, and D. Baltimore. 1986. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (London) 323:640-643.
  • Veldman, G. M., S. Lupton, and R. Kamen. 1985. Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression. Mol. Cell. Biol. 5:649-658.
  • Wasylyk, C., and B. Wasylyk. 1986. The immunoglobulin heavychain B-lymphocyte enhancer efficiently stimulates transcription in nonlymphoid cells. EMBO J. 5:553-560.
  • Weinberger, J., D. Baltimore, and P. A. Sharp. 1986. Distinct factors bind to apparently homologous sequences in the immunoglobulin heavy-chain enhancer. Nature (London) 322:846-848.
  • Zenke, M., T. Grundstrom, H. Matthes, M. Wintzerith, C. Schatz, A. Wildeman, and P. Chambon. 1986. Multiple sequence motifs are involved in SV40 enhancer function. EMBO J. 5:387-397.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.